{"entity":{"type":"insider","cik":"0001256088","url":"/insider/0001256088","json_url":"/insider/0001256088.json","name":"GEMAYEL GEORGES","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":12,"first":"2005-05-16","last":"2026-03-09","span_basis":"filed_date"},"name_variants":[{"name":"GEMAYEL GEORGES","source":"filing","n_filings":12,"first_seen":"2005-05-16","last_seen":"2026-03-09"}],"transactions":[{"id":6237920,"accession":"0001256088-26-000006","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001256088-26-000006","line_url":"/filing/0001256088-26-000006#line-3","is_derivative":false,"issuer_cik":"0001256088","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001256088","owner_cik":"0001256088","owner_name":"GEMAYEL GEORGES","owner_display_name":"GEMAYEL GEORGES","owner_url":"/insider/0001256088","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8787.0,"shares_display":"8,787","price_per_share":53.0,"price_display":"53.00","price_state":"stated","total_value":465711.0,"total_display":"465,711.00","total_whole":"465,711","shares_owned_after":27277.0,"shares_owned_after_display":"27,277","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-06","filed_date":"2026-03-09","scope":"insider"},{"id":6237912,"accession":"0001256088-26-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001256088-26-000006","line_url":"/filing/0001256088-26-000006#line-1","is_derivative":false,"issuer_cik":"0001256088","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001256088","owner_cik":"0001256088","owner_name":"GEMAYEL GEORGES","owner_display_name":"GEMAYEL GEORGES","owner_url":"/insider/0001256088","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":53.71,"price_display":"53.71","price_state":"stated","total_value":537100.0,"total_display":"537,100.00","total_whole":"537,100","shares_owned_after":28159.0,"shares_owned_after_display":"28,159","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-05","filed_date":"2026-03-09","scope":"insider"},{"id":2970425,"accession":"0001628280-24-047145","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-24-047145","line_url":"/filing/0001628280-24-047145#line-2","is_derivative":false,"issuer_cik":"0001256088","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001256088","owner_cik":"0001256088","owner_name":"GEMAYEL GEORGES","owner_display_name":"GEMAYEL GEORGES","owner_url":"/insider/0001256088","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10787.0,"shares_display":"10,787","price_per_share":36.3,"price_display":"36.30","price_state":"stated","total_value":391568.1,"total_display":"391,568.10","total_whole":"391,568","shares_owned_after":13315.0,"shares_owned_after_display":"13,315","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-08","filed_date":"2024-11-12","scope":"insider"},{"id":2326390,"accession":"0001628280-24-046666","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-24-046666","line_url":"/filing/0001628280-24-046666#line-2","is_derivative":false,"issuer_cik":"0001256088","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001256088","owner_cik":"0001256088","owner_name":"GEMAYEL GEORGES","owner_display_name":"GEMAYEL GEORGES","owner_url":"/insider/0001256088","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14213.0,"shares_display":"14,213","price_per_share":36.62,"price_display":"36.62","price_state":"stated","total_value":520480.06,"total_display":"520,480.06","total_whole":"520,480","shares_owned_after":13315.0,"shares_owned_after_display":"13,315","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-07","filed_date":"2024-11-08","scope":"insider"},{"id":2569204,"accession":"0001628280-24-040598","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-24-040598","line_url":"/filing/0001628280-24-040598","is_derivative":false,"issuer_cik":"0001256088","issuer_name":"SUPERNUS PHARMACEUTICALS, INC.","issuer_ticker":"SUPN","issuer_name_source":null,"issuer_url":"/issuer/0001256088","owner_cik":"0001256088","owner_name":"GEMAYEL GEORGES","owner_display_name":"GEMAYEL GEORGES","owner_url":"/insider/0001256088","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13886.0,"shares_display":"13,886","price_per_share":31.33,"price_display":"31.33","price_state":"stated","total_value":435048.38,"total_display":"435,048.38","total_whole":"435,048","shares_owned_after":13315.0,"shares_owned_after_display":"13,315","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-13","filed_date":"2024-09-17","scope":"insider","n_lines":2},{"id":2819300,"accession":"0001179110-20-008797","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-008797","line_url":"/filing/0001179110-20-008797#line-2","is_derivative":false,"issuer_cik":"0001235010","issuer_name":"MOMENTA PHARMACEUTICALS INC","issuer_ticker":"MNTA","issuer_name_source":null,"issuer_url":"/issuer/0001235010","owner_cik":"0001256088","owner_name":"GEMAYEL GEORGES","owner_display_name":"GEMAYEL GEORGES","owner_url":"/insider/0001256088","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":33.0,"price_display":"33.00","price_state":"stated","total_value":330000.0,"total_display":"330,000.00","total_whole":"330,000","shares_owned_after":14090.0,"shares_owned_after_display":"14,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-05","filed_date":"2020-08-07","scope":"insider"},{"id":2184488,"accession":"0001179110-20-008586","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-008586","line_url":"/filing/0001179110-20-008586#line-2","is_derivative":false,"issuer_cik":"0001235010","issuer_name":"MOMENTA PHARMACEUTICALS INC","issuer_ticker":"MNTA","issuer_name_source":null,"issuer_url":"/issuer/0001235010","owner_cik":"0001256088","owner_name":"GEMAYEL GEORGES","owner_display_name":"GEMAYEL GEORGES","owner_url":"/insider/0001256088","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":300000.0,"total_display":"300,000.00","total_whole":"300,000","shares_owned_after":14090.0,"shares_owned_after_display":"14,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-29","filed_date":"2020-07-30","scope":"insider"},{"id":6275068,"accession":"0000890465-14-000032","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000890465-14-000032","line_url":"/filing/0000890465-14-000032#line-2","is_derivative":false,"issuer_cik":"0000890465","issuer_name":"NPS PHARMACEUTICALS INC","issuer_ticker":"NPSP","issuer_name_source":null,"issuer_url":"/issuer/0000890465","owner_cik":"0001256088","owner_name":"GEMAYEL GEORGES","owner_display_name":"GEMAYEL GEORGES","owner_url":"/insider/0001256088","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6188.0,"shares_display":"6,188","price_per_share":37.7,"price_display":"37.70","price_state":"stated","total_value":233287.6,"total_display":"233,287.60","total_whole":"233,288","shares_owned_after":9000.0,"shares_owned_after_display":"9,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-13","filed_date":"2014-02-14","scope":"insider"},{"id":8434457,"accession":"0000732485-07-000037","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000732485-07-000037","line_url":"/filing/0000732485-07-000037#line-2","is_derivative":false,"issuer_cik":"0000732485","issuer_name":"GENZYME CORP","issuer_ticker":"GENZ","issuer_name_source":null,"issuer_url":"/issuer/0000732485","owner_cik":"0001256088","owner_name":"GEMAYEL GEORGES","owner_display_name":"GEMAYEL GEORGES","owner_url":"/insider/0001256088","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Genzyme common stock (GENZ)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37500.0,"shares_display":"37,500","price_per_share":76.0,"price_display":"76.00","price_state":"stated","total_value":2850000.0,"total_display":"2,850,000.00","total_whole":"2,850,000","shares_owned_after":9035.0,"shares_owned_after_display":"9,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-10-30","filed_date":"2007-11-02","scope":"insider"},{"id":9199589,"accession":"0000732485-06-000038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000732485-06-000038","line_url":"/filing/0000732485-06-000038#line-1","is_derivative":false,"issuer_cik":"0001256088","issuer_name":"GENZYME CORP","issuer_ticker":"GENZ","issuer_name_source":null,"issuer_url":"/issuer/0001256088","owner_cik":"0001256088","owner_name":"GEMAYEL GEORGES","owner_display_name":"GEMAYEL GEORGES","owner_url":"/insider/0001256088","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Genzyme common stock (GENZ)","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":56.47,"price_display":"56.47","price_state":"stated","total_value":169410.0,"total_display":"169,410.00","total_whole":"169,410","shares_owned_after":8030.0,"shares_owned_after_display":"8,030","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-05-11","filed_date":"2006-06-16","scope":"insider"},{"id":3672585,"accession":"0000732485-06-000019","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000732485-06-000019","line_url":"/filing/0000732485-06-000019#line-1","is_derivative":false,"issuer_cik":"0000732485","issuer_name":"GENZYME CORP","issuer_ticker":"GENZ","issuer_name_source":null,"issuer_url":"/issuer/0000732485","owner_cik":"0001256088","owner_name":"GEMAYEL GEORGES","owner_display_name":"GEMAYEL GEORGES","owner_url":"/insider/0001256088","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Genzyme common stock (GENZ)","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":56.47,"price_display":"56.47","price_state":"stated","total_value":169410.0,"total_display":"169,410.00","total_whole":"169,410","shares_owned_after":8030.0,"shares_owned_after_display":"8,030","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-05-11","filed_date":"2006-05-15","scope":"insider"},{"id":1593014,"accession":"0000732485-05-000051","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000732485-05-000051","line_url":"/filing/0000732485-05-000051#line-3","is_derivative":false,"issuer_cik":"0000732485","issuer_name":"GENZYME CORP","issuer_ticker":"GENZ","issuer_name_source":null,"issuer_url":"/issuer/0000732485","owner_cik":"0001256088","owner_name":"GEMAYEL GEORGES","owner_display_name":"GEMAYEL GEORGES","owner_url":"/insider/0001256088","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Genzyme common stock (GENZ)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7400.0,"shares_display":"7,400","price_per_share":68.61,"price_display":"68.61","price_state":"stated","total_value":507714.0,"total_display":"507,714.00","total_whole":"507,714","shares_owned_after":5578.0,"shares_owned_after_display":"5,578","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-07-15","filed_date":"2005-07-19","scope":"insider"},{"id":1306064,"accession":"0000732485-05-000022","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000732485-05-000022","line_url":"/filing/0000732485-05-000022#line-3","is_derivative":false,"issuer_cik":"0000732485","issuer_name":"GENZYME CORP","issuer_ticker":"GENZ","issuer_name_source":null,"issuer_url":"/issuer/0000732485","owner_cik":"0001256088","owner_name":"GEMAYEL GEORGES","owner_display_name":"GEMAYEL GEORGES","owner_url":"/insider/0001256088","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Genzyme common stock (GENZ)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":64.5,"price_display":"64.50","price_state":"stated","total_value":1612500.0,"total_display":"1,612,500.00","total_whole":"1,612,500","shares_owned_after":840.0,"shares_owned_after_display":"840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-05-12","filed_date":"2005-05-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001356576","name":"SUPERNUS PHARMACEUTICALS, INC.","url":"/issuer/0001356576","role":"Director","n_filings":4,"first_seen":"2024-09-17","last_seen":"2026-03-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001235010","name":"MOMENTA PHARMACEUTICALS INC","url":"/issuer/0001235010","role":"Director","n_filings":2,"first_seen":"2020-07-30","last_seen":"2020-08-07"},{"type":"issuer","type_label":"ISSUER","cik":"0000890465","name":"NPS PHARMACEUTICALS INC","url":"/issuer/0000890465","role":"Director","n_filings":1,"first_seen":"2014-02-14","last_seen":"2014-02-14"},{"type":"issuer","type_label":"ISSUER","cik":"0000732485","name":"GENZYME CORP","url":"/issuer/0000732485","role":"Officer (Executive Vice President)","n_filings":5,"first_seen":"2005-05-16","last_seen":"2007-11-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001256088","retrieved_at":"2026-08-27T08:39:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}